Table 5.

Comparison of outcomes of following active surveillance or immediate radical prostatectomy

Immediate radical prostatectomyActive surveillance
Treated100.00%63.68%
 Treated with Gleason score ≤6100.00%40.69%
 Treated with Gleason score 70.00%19.76%
 Treated with Gleason score ≥80.00%3.23%
Time to treatment
 ≤3 years27.75%
 >3 years35.93%
PSA at treatment (ng/mL)
 0–2.514.43%14.55%
 2.51–4.014.05%13.73%
 4.1–6.043.23%30.09%
 6.1–10.028.29%30.42%
 >10.00.00%11.21%
Cumulative incidence of recurrence from diagnosis
 20-year24.54%31.13%
 Lifetime29.38%37.61%
Cumulative incidence of prostate cancer death
 20-year1.64%2.78%
 Lifetime2.00%3.40%
Cumulative incidence of other cause death
 20-year51.60%51.13%
 Lifetime98.00%96.60%
Years of life per person from treatment19.6613.30
Total years of life per person from diagnosis19.6619.50
Years of life per person lost because of prostate cancer0.250.40

NOTE: Outcomes are based on 1 million simulated patients.